Invivyd Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $58.4M+129.9% YoYTTM through 30 Jun 2026
Net Income -$107.3MTTM through 30 Jun 2026
Free Cash Flow -$109.7MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| EBITDA Margin | -192.2% |
| Operating Margin | -313.6% |
| Net Margin | -183.9% |
Returns
-38.2%ROE
-32.1%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio6.47x
Net Debt-$184.2Mnet cash position
Cash & Equivalents$160.1M
Quality Metrics
Altman Z-Score-2.75
Piotroski F-Score2 / 9
FCF Margin-187.9%
Rule of 40-179.4
Earnings-Beat Rate33.3%
Multi-Year Trend
RevenueFY2025: $53.4M
Diluted EPS-$0.31TTMFY2025: $-0.30
Dividend
No dividend
Capital Allocation
Capex Intensity2.1%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.